
Enducef T 250mg/31.25mg Injection
Marketer
Endurance Healthcare Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Enducef T 250mg/31.25mg Injection
Cefixime and Sulbactam injection (250mg/31.25mg), marketed as Enducef T, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be under medical guidance; adhere strictly to the prescribed dosage schedule. Complete the full course, even with symptom improvement; premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and digestive upset. Escalating side effects necessitate immediate medical consultation. Seek emergency care for allergic reactions (rash, itching, swelling, breathing difficulties). Inform your physician of all concurrent medications, especially if pregnant or breastfeeding. Alcohol should be avoided due to potential increased drowsiness. While generally non-impairing, driving is discouraged if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration support recovery. Your doctor might order tests to monitor the medication's impact.
Primary Ingredients of Enducef T 250mg/31.25mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Enducef T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Enducef T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Enducef T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Enducef T 250mg/31.25mg Injection:
The medication will be administered by your physician or their qualified nurse. Self-medication is strictly prohibited.
How Enducef T 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Enducef T 250mg/31.25mg Injection, offer a targeted antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactum's role as a beta-lactamase inhibitor counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
The concomitant use of alcohol and Enducef T 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Enducef T, 250mg/31.25mg, is typically deemed safe for use in pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, data from human studies remain scarce.
Breast feedingCAUTION
Administering Enducef T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Enducef T 250mg/31.25mg Injection could lead to reduced awareness, visual impairment, drowsiness, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Enducef T 250mg/31.25mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The use of Enducef T 250mg/31.25mg Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Altering the dosage of Enducef T 250mg/31.25mg Injection is generally not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Enducef T 250mg/31.25mg Injection :
Should you forget a dose of Enducef T 250mg/31.25mg Injection, seek medical advice.
Facts to Know About Enducef T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Antimicrobial Agents |
